View in EDS

Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.

Saved in:
Bibliographic Details
Title: Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
Authors: Greter H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Ivol S; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Oriol Mathieu V; Janssen Vaccines & Prevention B.V, Archimedesweg 4, 2333 CN Leiden, Netherlands., Erismann S; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Prytherch H; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland., Steinmann P; Swiss Tropical and Public Health Institute, P.O. Box, CH-4002 Basel, Switzerland; University of Basel, Petersplatz 1, CH-4003 Basel, Switzerland. Electronic address: Peter.steinmann@swisstph.ch.
Source: Vaccine [Vaccine] 2021 Jan 15; Vol. 39 (3), pp. 580-587. Date of Electronic Publication: 2020 Dec 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2020.12.003